Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지

Taurine in Bone Formation and Alleviation of Its Diseases

타우린의 뼈 형성 작용과 관련질환의 경감

  • ;
  • Ramesh C. Gupta ;
  • 김미향 (경희대학교 치과대차 약리학교실) ;
  • ;
  • 김성진 (경희대학교 치과대차 약리학교실)
  • Published : 2002.09.01
Download PDF
⟨ Previous Next ⟩

Abstract

Taurine, amino acid, chemically known as 2-amino ethane sulphonic acid was discovered more than two hundred years ago from ox bile. it is widely distributed in both mammals and nonmammals. It is found in considerably high amount in hUl11an: a normal adult of 70 kgs contains about 70 grams of taurine. Taurine with this much concentration, is involved in almost all life processes. Its deficiency causes several abnormalities in major organs like brain, eye and heart. Taurine-bone interaction is latest addition to its long list of actions. In bone cells, taurine is also found in high concentration. Taurine is found to help in enhancing the bone tissue formation which is evidenced by increased matrix formation and collagen synthesis. Besides stimulating the bone tissue formation, it also inhibits the bone loss through inhibiting the bone resorption and osteoclast formation. Thus, taurine acts as a double agent. In addition to these two major actions of taurine in bone, it also has beneficial effect in wound healing mld bone repair. Taurine possess radioprotective properties, too. As it is a naturally available molecule, it can be used as a preventive agent. Taurine has a potential to replace bisphosphonates which are currently in use for the inhibition of bone loss but this needs in depth study. As taurine is involved in bone formation and inhibition of bone loss, a detailed study can make it a single marker of bone metabolism. All these taurine-bone interaction is a symbol of their deep involvement but still require further extension to make taurine as a choice for tile sound bone health.

Keywords

References

  1. Barthel T., Mechau D., Wehr T., Schnittker R., Liesen H. and Weiss M. (2001). Readiness potential in different states of physical activation and after ingestion of taurine and or cafferine containing drinks. Amino acids, 20, 63-73
  2. Birdsall T.C. (1998). Therapeutic Application of Taurine. Alt. Med. Rev., 3, 128-136
  3. Desal T.K., Maliakkol J., Kinxie J.L., Ehrinpreis M.N., Luk G.D. and Cejka J. (1992). Taurine deficiency after intensive chemotherapy and or radiaion. Am. J. Clin. Nutr., 55, 708-711 https://doi.org/10.1093/ajcn/55.3.708
  4. Hausmann E., Raisz L.G. and Miller W.A. (1990). Endotoxin; Stimulation of bone resorption in tissue culture. Science, 168, 862-864
  5. Huxtable R.J., and Nakagawa K. (1985). The Anticonvalsant actions of two Taurine derivatives in genetic and chemically induced seizures; Prog. in clinical and Biol. Res., 179, 435-448
  6. lino Y., and Hopps R.M. (1984). The bone resorbing activities in tissue culture of lipopolysaccharides from the bacteria Actinobacrilus actinomycetemcetem computions, Bacteroi-des, ainaival is and capnocytophage ochracea isolated from human month. Arch. Oral. Biol., 29, 59-63 https://doi.org/10.1016/0003-9969(84)90043-8
  7. Ishihara Y, Nishihara T, Maki E, Noguchi T, and Koga T (1991). Role of interleukin-l and prostaglandin in in vitro bone resorption induced by Actinobacillus actinomycetem-comitans lipopolysaccharid. J. Periodont Res., 26, 155-160 https://doi.org/10.1111/j.1600-0765.1991.tb01639.x
  8. Ishikawa YL, Chin JE, Schalk EM and Wuthier RE, 1986. Effect of amino acid levels on matrix vesicle formation by epiphyseal growth plate chondrocytes in primary culture. J. Cellular physiology, 126, 391-406
  9. Ito R., Henomatsu H., Uchiyama T. (1982). Difference between pre- and post-synaptic actions of sodium succinate and tau-rine in intracardiac sympathetic nerves (II). Changes after tooth-extraction-induced injuries in guinea pigs. Sulfur Amino Acids, 5., 113-121
  10. Ito R., Uchiyama T., Ohno H. and Kohda T. (1985). Proposal of cascade action of taurine related sulphur amino acids, on cardiac and vascular sympathetic Nerves; protection and Therapy of injuries after tooth extraction in Guinea pigs. Prog. Desal in Clincal and Biological Res., 179, 2155-224
  11. Koide M., Okahashi N., Tanaka R., Ka zuno K., Shibasaki K., Yamazaki Y., Kaneko K., Veda N., Ohguchi M., Ishihara Y., Noguchi T., and Nishihara T. (1999). Inhibition of experimental bone resorption and osteoclast formation and survival by 2-aminoe ethane sulphonic acid. Arch. Oral. Biol., 44, 711-719 https://doi.org/10.1016/S0003-9969(99)00067-9
  12. Lubec B., Ya-hua Z., Pertt S., Pentti T., Kitzmuller E. and G. Lubec G. (1997). Distribution and disappearance of the radio labled carbon derived from arginine and taurine in mouse. Lifesci, 60, 2378-2381
  13. Ozmeri C., Ozcan G,, Haytacc. M., Alaaddinoglu E.E., Sargon M.F. and Senel S. (2000). Chitosan film enriched with an antioxidant agent, taurine in fenestration defects. J. Biomed Mater. Res., 51, 500-503 https://doi.org/10.1002/1097-4636(20000905)51:3<500::AID-JBM26>3.0.CO;2-P
  14. Park S., Kim H. and Kim S.J. (2001). Stimulation of ERK2 by taurine with enhanced alkaline phosphatase activity and collagen synthesis in osteoblast like UMR-106 cells. Biochem. Phamacol., 62, 1107-1111 https://doi.org/10.1016/S0006-2952(01)00741-9
  15. Terauchi A., Nakazaw A., Johkura K., Yan L. and Usuda N. (1998). Immunoh Botochemical localization of taurme in various thissues of the mouse. Amino acids 15, 151-160 https://doi.org/10.1007/BF01345288
  16. Wilde M.I. and Wagstaff A.J. (1997). Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification. Drugs, 53, 10381053
  17. Wyhn R.L. (2000). Osteoporosis, alveolar bone loss and drug development General Dentistry 218-225